Chemotherapy For Castrate-Resistant Prostate Cancer

Chemotherapy for castrate resistant prostate cancer

Prechemotherapy Treatment Strategies in Castration-Resistant Prostate Cancer

Treatment Landscape of Castrate-Resistant Prostate Cancer

Abiraterone vs docetaxel for metastatic castrate resistant prostate cancer

Treatment options for patients with metastatic castration-resistant prostate cancer

Metastatic Castrate-Resistant Prostate Cancer: Options and Possible Sequences

Grand Rounds in Urology

Update on Mechanisms of Resistance in Castration-Resistant Prostate Cancer

Grand Rounds in Urology

01/14/2025 - Hi-Risk/Recurrent/Advanced PCa Men & Caregivers

AnCan Foundation

Updates in the treatment of castration-resistant prostate cancer

Ana Aparicio, MD, on metastatic castration-resistant prostate cancer patients and chemotherapy

Metastatic Castration Resistant Prostate Cancer (mCRPC) – Inroads in Improved Outcomes

Grand Rounds in Urology

How to treat men with advanced castration resistant prostate cancer with AR directed therapy

European Society for Medical Oncology (ESMO)

Castrate resistant prostate cancer

The Prostate Coach

Evolution of Treatment for Metastatic Castration-Resistant Prostate Cancer

The Challenges for Urologists Treating Metastatic Castrate Resistant Prostate Cancer Patients

Grand Rounds in Urology

Treating Patients With Progressive Metastatic Castration-Resistant Prostate Cancer

Targeted Oncology

Timing and Optimization of Radium 223 in Castration Resistant Prostate Cancer

Grand Rounds in Urology

Quality of life and new therapeutic options for metastatic castration-resistant prostate cancer

NCCN Guidelines for Patients with Castration-Resistant Metastatic Prostate Cancer

Dr. Charles Ryan Discusses Sequencing Prechemotherapy Castration-Resistant Prostate Cancer Therapies